AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research Agenda

Scientific Advances on the HIV Care Continuum Presented at CROI

CROI logo

Among the scientific advances highlighted at the 21st Conference of Retroviruses and Opportunistic Infections (CROI)  in Boston, Massachusetts this week were a number of new studies addressing the provision of essential care to persons living with HIV infection, including diagnosis, linkage and retention in care, initiation of antiretroviral treatment (ART), and achievement of durable viral…

Scientific Advances in HIV and Viral Hepatitis To Be Examined This Week at CROI

CROI logo

The 21st Conference on Retroviruses and Opportunistic Infections (CROI)  takes place this week in Boston. This annual scientific meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and related infectious diseases provides a vital forum for translating laboratory and clinical research into progress against these diseases. More than 4,000 HIV/AIDS research leaders…

NIH Names Leadership, Research Units for Restructured HIV/AIDS Clinical Trials Networks

nih logo

The National Institute of Allergy and Infectious Diseases (NIAID) has selected the principal investigators and clinical trials units (CTUs) that will lead and conduct the research of the five restructured HIV/AIDS clinical trials networks through 2021. The new structure is designed to create a broader, more flexible and more collaborative approach to the networks’ research priorities, which…

HIV Among MSM Examined at CROI

Ronald Valdiserri

The ongoing disproportionate burden of HIV/AIDS borne by gay, bisexual and other men who have sex with men (MSM) in the United States as well as around the world was the topic of a number of sessions and posters at the 20th Conference on Retroviruses and Opportunistic Infections  in Atlanta this week. In a compelling…

Daily-use HIV Prevention Approaches Didn’t Work for African Women in the VOICE Study

blog.aids.gov

According to findings of a major HIV prevention trial presented Monday, March 4, 2013 at the 20th Conference on Retroviruses and Opportunistic Infections (CROI), study participants who received daily oral pre-exposure prophylaxis (PrEP) did not experience any protection against HIV compared to those in the placebo arm, likely because very few were taking the study…

NIAID Advances Efforts to Restructure Clinical Trials Networks with Funding Announcements

NIAID wordle

Over the past year and a half, many of you followed the AIDS.gov blog post series Future Directions for NIAID HIV Research by Dr. Carl Dieffenbach, Director of the Division of AIDS, National Institute of Allergy and Infectious Diseases (NIAID) at NIH. Last week, NIAID advanced those efforts by issuing several requests for applications (RFAs)…

New Announcement about PrEP from NIH

NIAID

The National Institutes of Health National Institute of Allergy and Infectious Diseases just made a significant announcement on pre-exposure prophylaxis (PrEP). I am proud to share this important update from the NIH with our blog readers. Learn more by reading this Q&A.

Advancing Pediatric, Maternal and Child Health

Future Directions for NIAID HIV Research

Co-authored by Edward Handelsman, M.D., Chief of NIAID’s Pediatric Medicine Branch within the Division of AIDS, and Lynne Mofenson, M.D., Chief of the Pediatric, Adolescent and Maternal AIDS Branch within the Eunice Kennedy Shriver National Institute of Child Health & Human Development. As a result of our continued dialogue with our collaborators and stakeholders, NIAID…